These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

106 related articles for article (PubMed ID: 18053945)

  • 1. Stent thrombosis following drug-eluting stent implantation. A single-center experience.
    Vaknin-Assa H; Assali A; Ukabi S; Lev EI; Kornowski R
    Cardiovasc Revasc Med; 2007; 8(4):243-7. PubMed ID: 18053945
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Stent thrombosis after sirolimus- and paclitaxel-eluting stent implantation in daily clinical practice: analysis of a single center registry.
    Trabattoni D; Fabbiocchi F; Montorsi P; Ravagnani P; Galli S; Teruzzi G; Calligaris G; De Martini S; Bartorelli AL
    Catheter Cardiovasc Interv; 2007 Sep; 70(3):415-21. PubMed ID: 17722020
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Correlates and outcomes of late and very late drug-eluting stent thrombosis: results from DESERT (International Drug-Eluting Stent Event Registry of Thrombosis).
    Waksman R; Kirtane AJ; Torguson R; Cohen DJ; Ryan T; Räber L; Applegate R; Waxman S; Gordon P; Kaneshige K; Leon MB;
    JACC Cardiovasc Interv; 2014 Oct; 7(10):1093-102. PubMed ID: 25240540
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Failure of drug eluting stents presented as definite stent thrombosis.
    Vaknin-Assa H; Assali A; Lev EI; Ukabi S; Tamir B; Kornowski R
    Catheter Cardiovasc Interv; 2010 Jul; 76(1):93-7. PubMed ID: 20578093
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Late and very late drug-eluting stent thrombosis in the immediate postoperative period after antiplatelet withdrawal: a retrospective study.
    Omar HR; Sprenker C; Karlnoski R; Camporesi EM; Mangar D
    Ther Adv Cardiovasc Dis; 2014 Oct; 8(5):185-92. PubMed ID: 25015068
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Temporal relation between Clopidogrel cessation and stent thrombosis after drug-eluting stent implantation.
    Roy P; Bonello L; Torguson R; Okabe T; Pinto Slottow TL; Steinberg DH; Kaneshige K; Xue Z; Satler LF; Kent KM; Suddath WO; Pichard AD; Lindsay J; Waksman R
    Am J Cardiol; 2009 Mar; 103(6):801-5. PubMed ID: 19268735
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Two-year outcomes after first- or second-generation drug-eluting or bare-metal stent implantation in all-comer patients undergoing percutaneous coronary intervention: a pre-specified analysis from the PRODIGY study (PROlonging Dual Antiplatelet Treatment After Grading stent-induced Intimal hyperplasia studY).
    Valgimigli M; Tebaldi M; Borghesi M; Vranckx P; Campo G; Tumscitz C; Cangiano E; Minarelli M; Scalone A; Cavazza C; Marchesini J; Parrinello G;
    JACC Cardiovasc Interv; 2014 Jan; 7(1):20-8. PubMed ID: 24332420
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Stent thrombosis after drug-eluting stent implantation: incidence, timing, and relation to discontinuation of clopidogrel therapy over a 4-year period.
    Schulz S; Schuster T; Mehilli J; Byrne RA; Ellert J; Massberg S; Goedel J; Bruskina O; Ulm K; Schömig A; Kastrati A
    Eur Heart J; 2009 Nov; 30(22):2714-21. PubMed ID: 19596658
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Frequency of and risk factors for stent thrombosis after drug-eluting stent implantation during long-term follow-up.
    Park DW; Park SW; Park KH; Lee BK; Kim YH; Lee CW; Hong MK; Kim JJ; Park SJ
    Am J Cardiol; 2006 Aug; 98(3):352-6. PubMed ID: 16860022
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Stent thrombosis, clinical events, and influence of prolonged clopidogrel use after placement of drug-eluting stent data from an observational cohort study of drug-eluting versus bare-metal stents.
    Park DW; Yun SC; Lee SW; Kim YH; Lee CW; Hong MK; Cheong SS; Kim JJ; Park SW; Park SJ
    JACC Cardiovasc Interv; 2008 Oct; 1(5):494-503. PubMed ID: 19463351
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Antiplatelet therapy discontinuation and stent thrombosis after sirolimus-eluting stent implantation: five-year outcome of the j-Cypher Registry.
    Yano M; Natsuaki M; Morimoto T; Nakagawa Y; Kawai K; Miyazaki S; Muramatsu T; Shiode N; Namura M; Sone T; Oshima S; Nishikawa H; Hiasa Y; Hayashi Y; Nobuyoshi M; Mitsudo K; Kimura T;
    Int J Cardiol; 2015 Nov; 199():296-301. PubMed ID: 26226333
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Incidence of stent thrombosis and adverse cardiac events 5 years after sirolimus stent implantation in clinical practice.
    Goy JJ; Urban P; Kaufmann U; Seydoux C; De Benedetti E; Berger A
    Am Heart J; 2009 May; 157(5):883-8. PubMed ID: 19376316
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prognostic implications of early and long-term bleeding events in patients on one-year dual antiplatelet therapy following drug-eluting stent implantation.
    Musumeci G; Rossini R; Lettieri C; Capodanno D; Romano M; Rosiello R; Guagliumi G; Valsecchi O; Gavazzi A; Angiolillo DJ
    Catheter Cardiovasc Interv; 2012 Sep; 80(3):395-405. PubMed ID: 22109961
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Comparison of the incidence of late stent thrombosis after implantation of different drug-eluting stents in the real world coronary heart disease patients: three-year follow-up results.
    Chen JL; Gao LJ; Yang YJ; Li JJ; Qiao SB; Xu B; Huang JH; Yao M; Qin XW; Liu HB; Wu YJ; Yuan JQ; Chen J; You SJ; Dai J; Gao RL
    Chin Med J (Engl); 2010 Apr; 123(7):778-81. PubMed ID: 20497663
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Incidence and predictors of very late (>or=4 years) major cardiac adverse events in the DESIRE (Drug-Eluting Stents in the Real World)-Late registry.
    Costa JR; Sousa A; Moreira AC; Costa RA; Cano M; Maldonado G; Campos C; Carballo M; Pavanello R; Sousa JE
    JACC Cardiovasc Interv; 2010 Jan; 3(1):12-8. PubMed ID: 20129562
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Late angiographic stent thrombosis (LAST) events with drug-eluting stents.
    Ong AT; McFadden EP; Regar E; de Jaegere PP; van Domburg RT; Serruys PW
    J Am Coll Cardiol; 2005 Jun; 45(12):2088-92. PubMed ID: 15963413
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Incidence, predictors and outcome of drug-eluting stent thrombosis in real-world practice.
    Blich M; Zeidan-Shwiri T; Petcherski S; Osherov A; Hammerman H
    J Invasive Cardiol; 2010 Oct; 22(10):461-4. PubMed ID: 20944183
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comparison of Short- and Long-Term Cardiac Mortality in Early Versus Late Stent Thrombosis (from Pooled PROTECT Trials).
    Secemsky EA; Matteau A; Yeh RW; Steg PG; Camenzind E; Wijns W; McFadden E; Mauri L;
    Am J Cardiol; 2015 Jun; 115(12):1678-84. PubMed ID: 25910523
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Long-term outcome after drug-eluting versus bare-metal stent implantation in patients with ST-segment elevation myocardial infarction: 5 years follow-up from the randomized DEDICATION trial (Drug Elution and Distal Protection in Acute Myocardial Infarction).
    Holmvang L; Kelbæk H; Kaltoft A; Thuesen L; Lassen JF; Clemmensen P; Kløvgaard L; Engstrøm T; Bøtker HE; Saunamäki K; Krusell LR; Jørgensen E; Tilsted HH; Christiansen EH; Ravkilde J; Køber L; Kofoed KF; Terkelsen CJ; Helqvist S
    JACC Cardiovasc Interv; 2013 Jun; 6(6):548-53. PubMed ID: 23683734
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Optimal platelet inhibition after coronary stent implantation. Current status].
    Silber S; Hoffmeister HM; Bode C
    Herz; 2008 Jun; 33(4):244-53. PubMed ID: 18581073
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.